鎮痛剤ジコノチドによってブロックされたヒトのCav2.2チャネルの構造
Shuai Gao1, Xia Yao1, Nieng Yan2
1Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Nature
|July 8, 2021
まとめ
この研究では,ニューロン型 (N型) の電圧ゲートカルシウム (Cav) 2.2チャネルの構造と,痛み薬ジコノチドの結合方法が明らかになりました. これは,Cav2.2チャネルブロックと電機結合のための分子基盤を提供します.
科学分野:
- 神経科学
- 構造生物学
- 薬理学について
背景:
- ニューロン型 (N型) の電圧ゲートカルシウム (Cav) 2.2チャネルは神経伝達物質の放出に不可欠である.
- ジコノチドは,治療不可能な痛みに対する臨床的に使用されるCav2. 2特異的阻害剤です.
研究 の 目的:
- ジコノチドを含むヒトのCav2.2チャネルの冷凍電子顕微鏡構造を決定する.
- Cav2.2チャネルに対するジコノチドの毛穴阻害作用の分子メカニズムを解明する.
主な方法:
- 構造を解明するために冷凍電子顕微鏡 (cryo-EM) が使用されました.
- Cav2.2 (α1,α2δ-1,β3サブユニット) の構造は,ジコノチドの存在と不在で決定された.
主要な成果:
- ジコノチドは,Cav2.2の特定のヘリックスと細胞外ループによって調整され,細胞外ループとα2δ-1サブユニットの構成変化を誘導する.
- 3つの電圧感知ドメイン (VSD) は脱極化状態を採用し,一方VSDはユニークな細胞内セグメントと4,5-ビスホスファートによってダウン形状で安定化される.
- この研究は,シコノチドの正確な結合部位と,Cav2.2チャネル孔内の分子相互作用を明らかにした.
結論:
- この発見は,シコノチドがCav2.2チャネルをどのようにブロックするかを詳細な分子理解を提供します.
- この構造的枠組みは,Cavチャネルにおける電気機械的結合を調査し,新しい疼痛療法を開発するために不可欠です.
さらに関連する動画
関連する概念動画
Non-gated Ion Channels
7.6K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.1K
Mechanically-gated Ion Channels
7.1K
Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
7.1K
Voltage-gated Ion Channels
9.3K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
9.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.3K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
657
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
657


